Abstract.
Although clinical and histological criteria for ependymoma prognosis are recognized, studies have reported contradictory results. Prognostic significance based on immunohistochemistry of ependymomas has been described in a few studies and a strong prognostic value of p53 aberrant expression has been established. Recently, p53 regulation has found to be dependent on the function of the p14ARF gene product, which has been shown to be critically involved in human carcinogenesis. In this study we have examined patients with intracranial ependymomas (n=103) for immunoexpression of the novel antibody FL-132 to human p14ARF protein. We found that: (1) the polyclonal FL-132 antibody seems to be suitable for studying p14ARF protein status in routinely processed and paraffin-embedded specimens; (2) decreasing p14ARF protein expression is associated with patterns of ependymoma biological aggressiveness, i.e., increasing tumor grade, elevated growth fraction and p53 protein accumulation; however, there was no any association between p14 and MDM2 immunoexpression in ependymomas; (3) although the biological events underlying p14ARF inactivation in ependymal neoplasms are still unclear, FL-132 immunohistochemistry appears to be useful for assessing an individual prognosis in these tumors; when the p14 score was considered as "high" versus "low" (cut-off p14 labeling index at 10%), it represented an independent prognostic factor in both univariate and multivariate analyses (hazard ratio –3.56; P=0.0003); and (4) most beneficial information for evaluation of malignant ependymoma outcome should be elicited from simultaneous immunohistochemical investigation of p14 ARF and p53 in tumor specimen.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Revised, accepted: 6 February 2001
Electronic Publication
Rights and permissions
About this article
Cite this article
Korshunov, .A., Golanov, .A. & Timirgaz, .V. p14ARF protein (FL-132) immunoreactivity in intracranial ependymomas and its prognostic significance: an analysis of 103 cases. Acta Neuropathol 102, 271–277 (2001). https://doi.org/10.1007/s004010100379
Received:
Issue Date:
DOI: https://doi.org/10.1007/s004010100379